300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Angel Investors (May 2026)

The most active angel investors investing in Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Jonathan Milner
Angel
8 United Kingdom, United States, Canada Seed, Series A, Series B Biotechnology, Health Care, Medical $430k–$50M
Milad Alucozai
Angel
5 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical $91k–$60M
Sahin Boydas
Angel
4 United States Seed, Pre-Seed, Angel Robotics, Health Care, Consumer Electronics $4M–$34M
bumpkins profile
Angel
4 United States, Canada, India Seed, Series A, Pre-Seed Health Care, Biotechnology, Software $325k–$14M
Nadav Rosenberg
Angel
4 United Kingdom, Israel, Singapore Seed, Pre-Seed, Series A Biotechnology, Artificial Intelligence, Pharmaceutical $2M–$2M
Kevin Moore
Angel
3 United States, India, Canada Seed, Pre-Seed, Angel Software, Health Care, E-Commerce $120k–$3M
Erik Peterson
Angel
3 United States, Canada, Algeria Seed, Equity Crowdfunding, Series A Software, Biotechnology, SaaS $69k–$20M
Ian Hogarth
Angel
3 United Kingdom, United States, Germany Seed, Pre-Seed, Series A Software, E-Commerce, Health Care $123k–$12M
Chris Gibson
Angel
3 United States, France, United Kingdom Series A, Seed Biotechnology, Pharmaceutical, Health Care
Jude Gomila
Angel
3 United States, United Kingdom, Canada Seed, Pre-Seed, Angel Software, Biotechnology, Information Technology $190k–$3.1M
Esther Dyson
Angel
3 United States, Canada, Russian Federation Seed, Series A Health Care, Medical, Software $100k–$9.7M
Darian Shirazi
Angel
3 United States, Germany, Canada Seed, Series A, Series B Software, Information Technology, SaaS $1.9M–$118M
Stefano Bernardi
Angel
3 Italy, France, Norway Seed, Pre-Seed Biotechnology, Software, Artificial Intelligence $2M–$2M
Ed Parkinson
Angel
2 United Kingdom Seed Software, Health Care, Life Science
Nico Wittenborn
Angel
2 United States, Germany, Belgium Seed, Series A, Series B Wellness, Software, Health Care $1.6M–$88M
Darrin Disley
Angel
2 United Kingdom Seed, Series A Biotechnology, Health Care, Big Data $430k–$3.7M
Ahmed Abdelhamid
Angel
2 Egypt, United States Seed, Convertible Note Aerospace, Biopharma, Life Science
Patrick Yang
Angel
2 United States Series A, Seed, Series B Software, Health Care, E-Commerce $1.1M–$16M
Peter Harris
Angel
2 United States Seed Life Science, Biotechnology, Health Diagnostics $2.4M–$5M
Sauli Törmälä
Angel
2 Finland Seed Life Science, Biotechnology $589k–$1.3M
Andrew Nutter
Angel
2 France, United States, United Kingdom Seed, Pre-Seed Software, SaaS, Biotechnology $550k–$5.4M
Brian S. Cohen
Angel
2 United States, Israel Seed, Series A Software, SaaS, Mobile $100k–$2.5M
Thor Bjorgolfsson
Angel
2 United Kingdom, Germany Seed, Series A, Series C Big Data, TV, TV Production
Patrick Collison
Angel
2 United States, United Kingdom, Ireland Seed, Series A, Series C Software, Financial Services, Enterprise Software $2M–$31M
Jay Zaveri
Angel
2 United States, Japan, Canada Seed, Series A Health Care, Biotechnology, Information Technology $1M–$25M
Nicholas Edwards
Angel
2 United Kingdom Seed Medical, Health Care, Life Science
David Helgason
Angel
2 United States, Denmark, Finland Seed, Pre-Seed Software, Gaming, Information Technology $230k–$4.6M
James Hong
Angel
2 United States Seed, Series A, Angel E-Commerce, Mobile, Internet $975k–$25M
Jeff Dean
Angel
2 United States, United Kingdom Seed, Series A, Series B Artificial Intelligence, Biotechnology, Health Care $1.5M–$53M
Leena Niemistö
Angel
2 Finland, United States Seed, Pre-Seed Health Care, Software, E-Commerce $552k–$3M
Elad Gil
Angel
2 United States, United Kingdom, Israel Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $2M–$75M
Andrew Keys
Angel
2 United States, India, Germany Seed, Pre-Seed, Series A Finance, Software, Blockchain
Bradley Horowitz
Angel
2 United States, United Kingdom, Germany Seed, Series A, Series B Software, Information Technology, Health Care $125k–$50M
Michael Chambers
Angel
2 United States Series A Biotechnology, Genetics, Life Science
Nat Turner
Angel
2 United States, China Seed, Series A, Series B Health Care, Software, Medical $650k–$26M
KepalaBergetar TV
Angel
2 United States, France, United Kingdom Seed, Pre-Seed, Series A Software, Information Technology, Health Care $80k–$32M
Mike Novogratz
Angel
2 United States, India, Germany Seed, Series B Blockchain, Cryptocurrency, FinTech $7M–$7M
Sujay Jaswa
Angel
2 United States, Spain, Germany Seed, Series B, Series A Software, Media and Entertainment, Internet $11M–$85M
Zach Weinberg
Angel
2 United States, Israel, Colombia Seed, Series A, Series B Health Care, Software, Medical $750k–$40M
Craig Mundie
Angel
2 United States Seed, Series B, Series C Life Science, Chemical, Genetics
Ryan Bethencourt
Angel
2 United States, Chile, India Pre-Seed, Seed, Angel Biotechnology, Food Processing, Food and Beverage $100k–$945k
Carsten Maschmeyer
Angel
2 Germany, Austria, Switzerland Seed, Angel, Series A Software, Information Technology, Machine Learning $16k–$28M
Pierre Drion
Angel
2 Belgium Series A, Series B Biotechnology, Life Science, Software
Jan Hruska
Angel
2 United Kingdom Seed Medical, Health Care, Life Science
David R. Walt
Angel
2 United States Seed, Series A, Series B Biotechnology, Genetics, Life Science $2M–$5M
CJ Reim
Angel
2 United States Series A, Seed, Series B Robotics, E-Commerce, Internet $3.7M–$27M
Annie Vereecken
Angel
2 Belgium Seed, Series A Biotechnology, Medical, Hospital
Sam Altman
Angel
2 United States, Ghana, Canada Seed, Series A, Series B Software, Internet, E-Commerce $1.2M–$100M
Kathryn Haun
Angel
2 United States, United Kingdom Seed, Series A Blockchain, Financial Services, FinTech
Luc Vauterin
Angel
2 Belgium Seed, Series A Life Science, Data Integration, Data Visualization
Access all 397 angel investors in Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Jonathan Milner
Angel · Cambridge, Massachusetts, United States · 8 investments in Life Science startups

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 44
  • Round size: Seed $430k–$10M; Series A $1.8M–$18M; Series B $1.8M–$50M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Milad Alucozai
Angel · San Francisco, California, United States · 5 investments in Life Science startups

Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 47
  • Round size: Seed $91k–$4.5M; Pre-Seed $107k–$1.4M; Series A $25M–$60M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Arpeggio Bio — Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Show all investments...

Sahin Boydas
Angel · San Francisco Bay Area, California, United States · 4 investments in Life Science startups, 12 in the past 12 months

Sahin Boydas is the Head of RemoteTeam at Gusto.

Show more...

Investment focus

  • Industry: Robotics, Health Care, Consumer Electronics
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States

Investor stats

  • Total investments: 68
  • Round size: Seed $4M–$34M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Postman — Postman is a complete API development environment, used by nearly six million developers and more than 200,000 companies worldwide. It offers a platform for developers or enterprises to build, test, and debug their APIs. The platform intends to use the funds to continue to expand operations and its business reach.Postman is an elegant, flexibletool used to build connected software via APIs quickly, easily, and accurately. It enables API-first development, automated testing, and developer onboarding. The platform's features simplify each step of building an API and streamline collaboration so they can create better APIs faster. Postman was founded in 2014 and is headquartered in San Francisco and has an office in Bangalore, where it was founded. Postman is privately held, with funding from Nexus Venture Partners.
  • Owner.com — Save Money By Converting Third Party Orders To Order Through Your Website. Build Your Customer Database. Increase Sales With Automatic Text and Email Marketing. Setup For You. Built In Loyalty.
  • Shield AI — AI pilots will revolutionize battlefields and commercial aviation at a scale greater than the self-driving movement reshaping our highways.
Show all investments...

bumpkins profile
Angel · 4 investments in Life Science startups

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 49
  • Round size: Seed $2.9M–$9.1M; Pre-Seed $325k–$2M; Series A $10M–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
  • Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 4 investments in Life Science startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Pharmaceutical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Israel, Singapore

Investor stats

  • Total investments: 13
  • Round size: Pre-Seed $2M–$2M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • thymia — Making mental health as objectively measurable as physical health.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Loops — Loops is a no-code analytics platform that provides product and data teams with growth opportunities hidden in their data.
Show all investments...

Kevin Moore
Angel · Dallas, Texas, United States · 3 investments in Life Science startups

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, India, Canada

Investor stats

  • Total investments: 97
  • Round size: Seed $120k–$3M; Pre-Seed $120k–$2.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
  • Augmend — AI-augmented knowledge transfer across developers through a platform that captures and shares expertise.
Show all investments...

Erik Peterson
Angel · Chicago, Illinois, United States · 3 investments in Life Science startups

Erik Peterson is the Founder at DormTrader.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Seed, Equity Crowdfunding, Series A
  • Geography: United States, Canada, Algeria

Investor stats

  • Total investments: 59
  • Round size: Seed $150k–$4.5M; Series A $4M–$20M; Equity Crowdfunding $69k–$4.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.
Show all investments...

Ian Hogarth
Angel · London, England, United Kingdom · 3 investments in Life Science startups

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 40
  • Round size: Seed $1.5M–$12M; Pre-Seed $123k–$1.4M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
  • The Garden — The Garden is an online media company.
  • Condense — Live-streamed volumetric video into game engines
Show all investments...

Chris Gibson
Angel · Salt Lake City, Utah, United States · 3 investments in Life Science startups

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series A, Seed
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 8
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
  • Amenities — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
  • 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Show all investments...

Jude Gomila
Angel · San Francisco, California, United States · 3 investments in Life Science startups

Jude Gomila is currently CEO and Founder of the startup Golden.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 50
  • Round size: Seed $1.2M–$3.1M; Angel $190k–$1.3M; Pre-Seed $1.2M–$2M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
  • Monitaur — Reduce operational overhead, improve security, optimize performance, and deliver amazing customer experiences with our end-to-end, hybrid observability & APM platform built for decentralized apps and infrastructure.
  • Gradia Health — Gradia is an integrated, concierge care platform designed for clinics to support patients with chronic conditions.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Esther Dyson
Angel · New York, New York, United States · 3 investments in Life Science startups

Esther Dyson - Founder @ Way to Wellville

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Series A
  • Geography: United States, Canada, Russian Federation

Investor stats

  • Total investments: 69
  • Round size: Seed $100k–$2.5M; Series A $1M–$9.7M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Boxhub — Buy new & used shipping containers with Boxhub. We make buying a shipping container easy & deliver it right to your door. Buy a storage container today!
  • Way — Way is a mindful eating app that replaces restrictive diets.
  • Humanity — Slow down, or even, reverse your aging.
Show all investments...

Darian Shirazi
Angel · San Francisco, California, United States · 3 investments in Life Science startups, 20 in the past 12 months

Darian Shirazi is the General Partner of Gradient Ventures.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 116
  • Round size: Seed $1.9M–$9M; Series A $5M–$20M; Series B $50M–$118M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Resend — Build, test, and send transactional emails at scale.
  • Infisical — Infisical is an open-source, end-to-end encrypted tool that supports developers in managing their teams, devices, and infrastructure's secrets and environment variables. Using an end-to-end encrypted method, it avoids the leakage of confidential information to version control and over insecure channels like email.
  • Alongside — Alongside builds indexes for cryptocurrencies.
Show all investments...

Stefano Bernardi
Angel · San Francisco, California, United States · 3 investments in Life Science startups

Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Artificial Intelligence
  • Stage:Seed, Pre-Seed
  • Geography: Italy, France, Norway

Investor stats

  • Total investments: 13
  • Round size: Pre-Seed $2M–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Freatic — We bridge the gap between individuals with untapped knowledge and actors who can take advantage of these opportunities.
  • Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
  • CaSRevolution — A novel disease-modifying approach against neurodegeneration
Show all investments...

Ed Parkinson
Angel · 2 investments in Life Science startups

Ed Parkinson

Show more...

Investment focus

  • Industry: Software, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Antiverse — Designing biologics for 100 challenging targets
Show all investments...

Nico Wittenborn
Angel · New York, New York, United States · 2 investments in Life Science startups

Nico Wittenborn is an Investor at Adjacent.

Show more...

Investment focus

  • Industry: Wellness, Software, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Belgium

Investor stats

  • Total investments: 29
  • Round size: Seed $1.6M–$5.4M; Series A $26M–$40M; Series B $9M–$88M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Captions — Say hello to Captions, the only camera and editing app that automatically transcribes, captions and clips your talking videos for you.
  • Backbone — Backbone is a mobile gaming controller with intuitive controls, clickable thumbsticks & zero latency that works with cloud and remote gaming.
  • Momentum — Momentum builds fundraising software and expert guidance for nonprofits
Show all investments...

Darrin Disley
Angel · Cambridge, Cambridgeshire, United Kingdom · 2 investments in Life Science startups

Darrin Disley is the CEO, Director & Investor at Mogrify. He attended University of Cambridge.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Big Data
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Seed $430k–$3.7M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • Desktop Genetics — Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by thereal-world impact of CRISPR technology.They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics. Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive.
Show all investments...

Ahmed Abdelhamid
Angel · 2 investments in Life Science startups

Ahmed Abdelhamid is Partner at Endure Capital. He attended Vlerick Business School.

Show more...

Investment focus

  • Industry: Aerospace, Biopharma, Life Science
  • Stage:Seed, Convertible Note
  • Geography: Egypt, United States

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
  • Wright Electric, Inc. — Wright Electric, Inc. is building technologies for large commercial airplanes. The company is currently developing their flagship Airplane, the Wright 1, which will be a 186-seat single aisle airliner with an 800 mile range. The company hopes to achieve entry to service for the Wright 1 by 2030 and is working with commercial airlines includingeasyJet and VivaAerobus. In addition to the newly announced U.S. DOE’s ARPA-E funding, the company is funded by Y Combinator, the Clean Energy Trust and venture funds.
Show all investments...

Patrick Yang
Angel · San Francisco, California, United States · 2 investments in Life Science startups

Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Series A, Seed, Series B
  • Geography: United States

Investor stats

  • Total investments: 27
  • Round size: Seed $1.1M–$5.6M; Series A $5M–$16M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.
Show all investments...

Peter Harris
Angel · 2 investments in Life Science startups

Peter Harris

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: United States

Investor stats

  • Total investments: 2
  • Round size: Seed $2.4M–$5M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • CND Life Sciences — Our suite of neurodiagnostic tests give clinicians access to objective pathological insights on diseases that are often difficult to diagnose
Show all investments...

Sauli Törmälä
Angel · Helsinki, Southern Finland, Finland · 2 investments in Life Science startups

Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Round size: Seed $589k–$1.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Andrew Nutter
Angel · Paris, Ile-de-France, France · 2 investments in Life Science startups

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Show more...

Investment focus

  • Industry: Software, SaaS, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 22
  • Round size: Seed $550k–$5.4M; Pre-Seed $780k–$3.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Yavin — Yavin provides modern point-of-sale solutions for European merchants
  • Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
  • EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Show all investments...

Brian S. Cohen
Angel · New York, New York, United States · 2 investments in Life Science startups

Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.

Show more...

Investment focus

  • Industry: Software, SaaS, Mobile
  • Stage:Seed, Series A
  • Geography: United States, Israel

Investor stats

  • Total investments: 44
  • Round size: Seed $100k–$2.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
  • CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
  • Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.
Show all investments...

Thor Bjorgolfsson
Angel · London, England, United Kingdom · 2 investments in Life Science startups

Thor Bjorgolfsson - Entrepreneur, Businessman and Adventure Capitalist Thor Bjorgolfsson, Iceland’s first and only current billionaire, is an investor and business innovator who is not afraid of risk. He has been an entrepreneur since childhood, making his first deal at the age of 10, when he purchased a stack of vintage Marvel comics withborrowed money.In 2004, he founded Novator Partners, an alternative investment firm. He has strategically developed the company to allow it to maintain maximum flexibility as well as to facilitate investments in both strategic (buy and hold) and financial (buy and exit) opportunities.With Novator, Thor leverages private equity as well as macro investments and manages assets across a variety of sectors and geographic locations. He is an active investor in emerging economies including Central and Eastern Europe as well as Latin America.Novator Partners has been a major player in telecom businesses. Thor is a stakeholder in a Polish telecom company called Play, which went public in 2017. In addition, he holds shares in WOM, a Chilean telecommunications firm.Bjorgolfsson’s first fortune was made in post-soviet Russia. At a time when others perceived Russia to be tumultuous, he saw an underserved market that presented an exciting opportunity to invest in great ideas and businesses. He co-founded and developed Bravo Brewery, which produced beer and alcopops. Bravo became one of Russia’s premier brewing companies, particularly through its popular Botchkarov beer brand. Thor sold the business in 2002 to Heineken for $100 million.With the sale of Bravo, he was able to diversify his holdings by reinvesting in new ventures, focusing on telecommunications, pharmaceuticals, and banks. In a few years, he was able to turn that $100 million into a net worth of over $2.1 billion.A year after being featured on the 2007 cover of Forbes Magazine, Iceland went nearly bankrupt overnight and Thor found himself at the epicenter of the financial crisis. As a major shareholder in Landsbanki with personal guarantees of 350m euro, he refused to declare bankruptcy and eventually succeeded in paying off all of it. He then went on to invest in new businesses, re-establishing himself and being featured on the Forbes list of billionaires once again.During this time of rejuvenation, he wrote Billions to Bust and Back: How I Made, Lost and Rebuilt a Fortune, And What I Learned on the Way (2014). In the book, he shares his perspective of what it was like to be at the center of the storm and how he made it back to financial success. He proposes that the greatest strength an entrepreneur can possess is a positive attitude.The 52-year-old Thor was educated in the United States where he earned a Bachelor of Science degree from New York University. In 2005, he was honored as a Young Global Leader by the World Economic Forum. In spite of his intense schedule, Thor enjoys sharing his experience and business insight, making him a sought-after speaker. A multilingual Icelandic citizen, Thor spends most of his time in London, living with his wife and three children. Thor's personal passion is his collection of six motorcycles, which he rides whenever time permits.

Show more...

Investment focus

  • Industry: Big Data, TV, TV Production
  • Stage:Seed, Series A, Series C
  • Geography: United Kingdom, Germany

Investor stats

  • Total investments: 6
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Olvin — Using foot traffic analytics to help your business make the right decisions. Get started to access world class data and actionable insights.
  • DNEG — We are DNEG, one of the world's leading visual effects and animation studios for feature film and television, honoured with the Academy Award six times
  • ATAI Life Sciences — ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in themental health space.ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.
Show all investments...

Patrick Collison
Angel · San Francisco, California, United States · 2 investments in Life Science startups

Patrick Collison is a Content Strategist for Stripe.

Show more...

Investment focus

  • Industry: Software, Financial Services, Enterprise Software
  • Stage:Seed, Series A, Series C
  • Geography: United States, United Kingdom, Ireland

Investor stats

  • Total investments: 42
  • Round size: Seed $2M–$9M; Series A $7M–$31M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Polywork — A network that doesn’t restrict you to telling your story through a list of arbitrary job titles; that doesn’t let any random stranger you’ve never even met endorse you for skills you never knew you had. They want to build a network that empowers you and gives you control over your identity and your future opportunities.
  • Rain Industries — Every wildfire starts small. Rain contains wildfires within 10 minutes of ignition with autonomous drones.
  • keen technologies — keen technologies provides SAP education and other skill based education that needs to the students in current market needs.
Show all investments...

Jay Zaveri
Angel · San Francisco Bay Area, California, United States · 2 investments in Life Science startups

Jay Zaveri has been serving Social Capital as a partner since November 2015. He also founded CloudOn and Future Thought Productions.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: United States, Japan, Canada

Investor stats

  • Total investments: 58
  • Round size: Seed $1M–$4M; Series A $3M–$25M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
  • BitClout — BitClout is a platform owned by its users. Bitcoin is decentralizing money, BitClout is decentralizing social media.
  • Kingdom Supercultures — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Show all investments...

Nicholas Edwards
Angel · Oxford, Oxfordshire, United Kingdom · 2 investments in Life Science startups

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

David Helgason
Angel · Copenhagen, Hovedstaden, Denmark · 2 investments in Life Science startups

David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.

Show more...

Investment focus

  • Industry: Software, Gaming, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United States, Denmark, Finland

Investor stats

  • Total investments: 62
  • Round size: Seed $600k–$4.6M; Pre-Seed $230k–$2M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Isometric — Isometric is a carbon removal registry and science platform
  • TreesPlease Games — TreesPlease Games develops various computer and online games. The company is headquartered in London.
  • Scriptic — Scriptic, interactive story games on mobile.
Show all investments...

James Hong
Angel · San Francisco, California, United States · 2 investments in Life Science startups

James Hong

Show more...

Investment focus

  • Industry: E-Commerce, Mobile, Internet
  • Stage:Seed, Series A, Angel
  • Geography: United States

Investor stats

  • Total investments: 28
  • Round size: Seed $1M–$3.7M; Angel $975k–$3M; Series A $1M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Hatch — At Hatch, we're dreaming up ways to help people sleep better. Our sleep products and services have helped over a million people get a good night's rest. We're on a mission to make sleep easier for everyone with innovative, all-in-one solutions for newborns through adults.
  • Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Show all investments...

Jeff Dean
Angel · Palo Alto, California, United States · 2 investments in Life Science startups, 9 in the past 12 months

Jeff Dean joined Google in 1999 and is currently a Google Senior Fellow in Google's Research Group, where he leads the Google Brain team, Google's deep learning research team in Mountain View, working on systems for speech recognition, computer vision, language understanding, and various predictive tasks. He has co-designed /implemented five generations of Google's crawling, indexing, and query serving systems, and co-designed / implemented major pieces of Google's initial advertising and AdSense for Content systems. He is also a co­designer and co­implementor of Google's distributed computing infrastructure, including the MapReduce, BigTable and Spanner systems, protocol buffers, LevelDB, and TensorFlow, a popular open­-source system for machine learning.​Jeff received a Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the Mark Weiser Award and the ACM­-Infosys Foundation Award in the Computing Sciences.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 30
  • Round size: Seed $1.5M–$12M; Series A $6.1M–$20M; Series B $53M–$53M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Luda — Lifting people through play
  • Elicit — Elicit is an artificial intelligence research assistant that uses language models to help users automate research workflows. This research assistant finds relevant papers without a perfect keyword match, summarizes takeaways from the papers, and extracts key information from the papers.
  • Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Leena Niemist&ouml;
Angel · Helsinki, Southern Finland, Finland · 2 investments in Life Science startups

Leena Niemistö

Show more...

Investment focus

  • Industry: Health Care, Software, E-Commerce
  • Stage:Seed, Pre-Seed
  • Geography: Finland, United States

Investor stats

  • Total investments: 14
  • Round size: Seed $552k–$3M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • #Rens — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
  • Vapaus — A circular economy startup Vapaus provides sustainable mobility solutions – Employee benefit bicycles and shared electric vehicles as a ready-to-use serviceWith its services, Vapaus supports customers’ to create and strengthen a better experience of the work community, to save on the costs of commuting and business travels, and to move towardssmarter and more environmentally friendly modes of transport, both at work and in employees’ leisure time.Every kilometer traveled by the Vapaus mobility solution removes carbon dioxide from the air, helping not only the environment but also customers on their way to carbon neutrality. The mission of Vapaus is to be a global leader when it comes to sustainable Corporate Mobility.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Elad Gil
Angel · San Francisco, California, United States · 2 investments in Life Science startups, 20 in the past 12 months

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 170
  • Round size: Seed $2M–$7M; Series A $10M–$30M; Series B $20M–$75M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Resend — Build, test, and send transactional emails at scale.
  • Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
  • Neon — Postgres made for developers. Easy to Use, Scalable, Cost efficient solution for your next project.
Show all investments...

Andrew Keys
Angel · 2 investments in Life Science startups

Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.

Show more...

Investment focus

  • Industry: Finance, Software, Blockchain
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Germany

Investor stats

  • Total investments: 9
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Evertas — Evertas brings this unchanging approach to the new space of crypto assets. Our goal is to help crypto realize its full potential, for everyone.
  • Aligned — Aligned is building a suite of products and services aimed to empower the growing decentralized financial movement spanning high performance computing, mining, staking and liquidity provisioning while supporting decentralization with immutable, full-stack infrastructure for DeFi.
  • Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Show all investments...

Bradley Horowitz
Angel · Palo Alto, California, United States · 2 investments in Life Science startups

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 92
  • Round size: Seed $125k–$12M; Series A $5M–$31M; Series B $19M–$50M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • T2 — T2 is in early alpha. 280 character text, replies, and likes - that's it for now. Browse content now and sign up for the waitlist.
  • Mill — So long, smelly bags. Goodbye, greenhouse gasses. Reserve your membership today and make a real difference from your kitchen.
  • Meander — Vektor is the career platform for Tech professionals.
Show all investments...

Michael Chambers
Angel · Fargo, North Dakota, United States · 2 investments in Life Science startups

Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.

Show more...

Investment focus

  • Industry: Biotechnology, Genetics, Life Science
  • Stage:Series A
  • Geography: United States

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
  • Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
  • 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Show all investments...

Nat Turner
Angel · New York, New York, United States · 2 investments in Life Science startups

Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerousinternet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, China

Investor stats

  • Total investments: 71
  • Round size: Seed $650k–$5M; Series A $1M–$15M; Series B $18M–$26M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
  • Collectors — Helping collectors to pursue their passion.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Show all investments...

KepalaBergetar TV
Angel · New York, New York, United States · 2 investments in Life Science startups

Malay website serving the people of Malaysia and all other nations with a need for live filem and Malay dramas that people love and react to with emotion, ready to push all boundaries.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 101
  • Round size: Seed $321k–$4M; Pre-Seed $80k–$2.5M; Series A $2.5M–$32M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Dassana — Introducing the industry's first consumption-based security data lake. Dirt cheap. SQL over JSON. Index-free.
  • Poolit — Poolit unlocks access to exclusive alternative investments with top private equity and venture capital funds. Invest for as little as $1 - a first for private markets.
  • Basetwo AI — Building digital twins for manufacturing just got easier
Show all investments...

Mike Novogratz
Angel · New York, New York, United States · 2 investments in Life Science startups

Michael E. Novogratz is the CEO of Galaxy Investment Partners. He was formerly a principal and a member of the board of directors of Fortress Investment Group LLC and Chief Investment Officer of the Fortress Macro Fund. Mr. Novogratz joined Fortress in 2002 after spending 11 years at Goldman Sachs, where he was elected partner in 1998. Mr.Novogratz founded and serves as the Chairman of the Board for Beat the Streets, a non-profit organization which builds wrestling programs in New York City public schools and is also the Honorary Chairman of USA Wrestling Foundation. Mr. Novogratz is Chairman of The Friends of the Hudson River Park. He also serves on the board of the Acumen Fund, NYU Langone Medical Center, Princeton Varsity Club and The Jazz Foundation of America. Mr. Novogratz received an AB from Princeton University in Economics, and served as a helicopter pilot in the US Army.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, FinTech
  • Stage:Seed, Series B
  • Geography: United States, India, Germany

Investor stats

  • Total investments: 20
  • Round size: Seed $7M–$7M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • Portal — Portal is a financial services company that trades crypto anywhere without putting coins at risk, all from within a controllable wallet. Founded in 2018, Portal is headquartered in San Francisco, California.
  • Verandah — Verandah is story based conscious luxury resort brand retailing amongst the top 100 in the global luxury resort wear space with design roots strongly based in India. Verandah also has a line of 100% Italian made sustainable swimwear to compliment the season-less ready to wear line.
  • Cambrian Biopharma — Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.
Show all investments...

Sujay Jaswa
Angel · San Francisco, California, United States · 2 investments in Life Science startups

Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.

Show more...

Investment focus

  • Industry: Software, Media and Entertainment, Internet
  • Stage:Seed, Series B, Series A
  • Geography: United States, Spain, Germany

Investor stats

  • Total investments: 27
  • Round size: Series A $11M–$30M; Series B $31M–$85M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products. 
e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
  • point.me — Maximize your miles with our real-time search engine. Easily compare reward flights across airlines to find the best deal. So you get better flights, for fewer points.
  • Fireside — Fireside is the first interactive streaming platform that invites you to be part of the show. Co-founded by Falon Fatemi and Mark Cuban the media and entertainment networks of the future are emerging on Fireside.
Show all investments...

Zach Weinberg
Angel · New York, New York, United States · 2 investments in Life Science startups

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, Colombia

Investor stats

  • Total investments: 68
  • Round size: Seed $750k–$5M; Series A $1M–$15M; Series B $18M–$40M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
  • Overwatch Research — Generate accurate in vivo study data with modern software designed for data capture, collaboration, and insights.
Show all investments...

Craig Mundie
Angel · 2 investments in Life Science startups

Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.

Show more...

Investment focus

  • Industry: Life Science, Chemical, Genetics
  • Stage:Seed, Series B, Series C
  • Geography: United States

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Stoicheia — Stoicheia is a nanotechnology company accelerating materials discovery by defining and expanding the materials genome. Using its proprietary lithography technology, Stoicheia has developed a way to create Megalibraries of nanomaterials on a chip. The company's technology also can be used to combine elements in new ways — already creatingstructures comprising up to seven elements.
  • Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ryan Bethencourt
Angel · San Francisco, California, United States · 2 investments in Life Science startups

Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.

Show more...

Investment focus

  • Industry: Biotechnology, Food Processing, Food and Beverage
  • Stage:Pre-Seed, Seed, Angel
  • Geography: United States, Chile, India

Investor stats

  • Total investments: 14
  • Round size: Pre-Seed $100k–$945k
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
  • Sobo Foods — Sobo Foods is a plant based comfort food provider.
  • Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Show all investments...

Carsten Maschmeyer
Angel · Hanover, Niedersachsen, Germany · 2 investments in Life Science startups, 19 in the past 12 months

Carsten Maschmeyer is a successful entrepreneur, consultant and financial investor. He was born on May 8, 1959 in Bremen and grew up in Hildesheim. After his graduation in 1978 Maschmeyer completed military service before he began to study medicine in Hannover. To finance his studies, he worked part-time in sales of investment advice to it in 1982completely dedicated financial advice. More about Carsten Masch Meyers consultant. In 1988 Carsten Maschmeyer to AWD financial group, which was successfully launched on the stock market in 2000 and rise to the MDAX and expanded in 11 countries. Was sold in 2007 Carsten Maschmeyer all his shares in the company at the insurance group Swiss Life, who renamed the AWD in AWD Holding. Maschmeyer has today different occupational focuses, inter alia, as entrepreneur, investor and consultant. His experience Carsten Maschmeyer a sought-after speaker on the subject of success. Motivated by the desire expressed by many listeners to learn more about his secret of success, Carsten Maschmeyer published in the spring of 2012 his book "Self Made - performance live richly". In it he describes the basis of his own exciting path and the celebrities strategies for professional, financial and personal success.

Show more...

Investment focus

  • Industry: Software, Information Technology, Machine Learning
  • Stage:Seed, Angel, Series A
  • Geography: Germany, Austria, Switzerland

Investor stats

  • Total investments: 61
  • Round size: Seed $16k–$2.8M; Angel $96k–$643k; Series A $1.6M–$28M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • frats — frats' goal is to become a solution-oriented company in the party, event, and festival market for sustainable products.
  • Futurised — Futurized makes processes simple and intelligent by providing businesses with software robots that automate all unpleasant and complex operations using AI.
  • Bildungs urlauber — The goal of Bildungsurlauber.de is to make complicated topics simple. First and foremost, we assist you in locating the appropriate seminar for you by using simple filter options - regardless of whatever federal state you work in.
Show all investments...

Pierre Drion
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Life Science startups

Pierre Drion - CEO @ Petercam

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Software
  • Stage:Series A, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.
Show all investments...

Jan Hruska
Angel · 2 investments in Life Science startups

Jan Hruska

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Show all investments...

David R. Walt
Angel · Boston, Massachusetts, United States · 2 investments in Life Science startups

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.

Show more...

Investment focus

  • Industry: Biotechnology, Genetics, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 8
  • Round size: Seed $2M–$5M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
  • Stoicheia — Stoicheia is a nanotechnology company accelerating materials discovery by defining and expanding the materials genome. Using its proprietary lithography technology, Stoicheia has developed a way to create Megalibraries of nanomaterials on a chip. The company's technology also can be used to combine elements in new ways — already creatingstructures comprising up to seven elements.
  • Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Show all investments...

CJ Reim
Angel · San Francisco, California, United States · 2 investments in Life Science startups

CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.

Show more...

Investment focus

  • Industry: Robotics, E-Commerce, Internet
  • Stage:Series A, Seed, Series B
  • Geography: United States

Investor stats

  • Total investments: 15
  • Round size: Seed $3.7M–$4.3M; Series A $16M–$27M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Show all investments...

Annie Vereecken
Angel · 2 investments in Life Science startups

Annie Vereecken

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Hospital
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Sam Altman
Angel · San Francisco, California, United States · 2 investments in Life Science startups, 17 in the past 12 months

Sam Altman is the co-founder and CEO of OpenAI. Sam was previously the Chairman of Y Combinator, a leading silicon valley startup accelerator.

Show more...

Investment focus

  • Industry: Software, Internet, E-Commerce
  • Stage:Seed, Series A, Series B
  • Geography: United States, Ghana, Canada

Investor stats

  • Total investments: 143
  • Round size: Seed $1.2M–$10M; Series A $4M–$36M; Series B $23M–$100M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Induced AI — Induced AI works to automate browser tasks. It runs a cloud to complete manual tasks on a browser with human-like reasoning capabilities.
  • teachme.to — Teachme.to is a community of learners discovering lessons for everything.
  • Vital Bio — Reinventing diagnostics for proactive & accessible care. Diagnostics designed for better outcomes. Eliminating gaps between care and treatment.
Show all investments...

Kathryn Haun
Angel · San Francisco, California, United States · 2 investments in Life Science startups

Katie Haun is a General Partner at Andreessen Horowitz. She serves on the boards of Coinbase and HackerOne and has invested in and advised tech companies from seed to Series E stage. Katie teaches a management course at Stanford Business School and previously taught cybercrime at Stanford Law School. Previously, she spent a decade as a federalprosecutor with the U.S. Department of Justice focusing on fraud, cyber, and corporate crime alongside agencies including the SEC, FBI, and Treasury. She created the government’s first cryptocurrency task force and led investigations into the Mt. Gox hack and the corrupt agents on the Silk Road task force. She also prosecuted RICO murders, organized crime, public corruption, gangs, and money laundering, and held senior policy positions at headquarters in both the National Security Division and Attorney General’s office where her portfolio included antitrust, tax, and national security. Katie clerked for U.S. Supreme Court Justice Anthony Kennedy and is an honors graduate of Stanford Law School.

Show more...

Investment focus

  • Industry: Blockchain, Financial Services, FinTech
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom

Investor stats

  • Total investments: 20
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Aptos — Committed to developing products and applications on the Aptos blockchain that redefine the web3 user experience.
  • Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
  • Autograph — Autograph is an NFT platform that brings together the most iconic brands and legendary names in sports, entertainment and culture to create unique digital collections and experiences.
Show all investments...

Luc Vauterin
Angel · 2 investments in Life Science startups

Luc Vauterin - Board Member @ ONTOFORCE

Show more...

Investment focus

  • Industry: Life Science, Data Integration, Data Visualization
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Show all investments...

Life Science Angel investor funding at a glance

Stats across 308 deals from 397 investors.

397
investors
in Life Science startups
308
deals
in Life Science startups
$4M
median round
in Life Science startups
7%
lead investors
lead at least one round
39%
Seed
most common funding stage

Access all 397 angel investors in Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Angel Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 397 angel investors investing in Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists